GET DAILY SIGNALSWhy Is Grindr (GRND) Stock Up +2.13% Today?
Key Takeaways
- GRND shares rose 2.13% to $13.93, adding $0.29 from the prior session's close of $13.64.
- The move marks a post-earnings rebound after the stock initially slipped on a "sell the news" reaction to a one-time GAAP loss.
- Third-quarter revenue grew 22% to $141 million, beating consensus, and management raised full-year 2026 guidance.
- Goldman Sachs lifted its price target to $20 from $19, reinforcing bullish sentiment.
- Traders are watching the launch of the Edge AI subscription tier and integration of the Freddie telehealth acquisition.
- For more details on analyst expectations, explore Price Targets, Earnings, and Forecast.
- Interested in automated strategies? Browse Tickeron's Trending AI Robots for data-driven trading ideas.
Opening Summary
Grindr Inc. (GRND), the world's largest social networking and dating platform for the LGBTQ+ community, traded higher on Thursday, with shares climbing 2.13% to $13.93, up $0.29 from Wednesday's closing price of $13.64. The gain represents a rebound after the stock fell 2.64% in the prior session, when investors initially reacted cautiously to the company's third-quarter earnings report. Markets attributed the renewed strength to a quarterly revenue beat, an upward revision to full-year guidance, an initial 2027 outlook that topped expectations, and a supportive analyst action from Goldman Sachs.
Earnings Beat and Raised Guidance
The central driver behind the move was Grindr's third-quarter 2026 results, released after the market close on November 5. Revenue rose 22% year over year to $141 million, ahead of the roughly $135 million consensus estimate, while adjusted EPS of $0.18 edged past the $0.17 forecast. Adjusted EBITDA reached $62 million, reflecting a 44% margin.
Management also raised its full-year 2026 revenue guidance to at least $560 million, up from approximately $540 million, and lifted its adjusted EBITDA outlook to at least $236 million. Notably, the company provided an initial 2027 forecast calling for revenue of at least $705 million and adjusted EBITDA of at least $275 million, figures that came in above consensus and signaled confidence in the company's growth trajectory.
AI Tier and Healthcare Expansion Fuel Optimism
Investors also responded to the company's product roadmap. Grindr is launching "Edge," an AI-powered premium subscription tier priced at $120 per month, which reportedly drew nearly 400,000 early-access registrations within 72 hours of announcement. The strong initial demand underscores the pricing power of the platform's engaged user base.
Separately, Grindr completed its acquisition of PurposeMed, the parent of HIV-prevention telehealth provider Freddie, in early November. The deal advances the company's "Grindr Health" initiative and adds a high-margin, recurring healthcare revenue stream, a key pillar of the longer-term growth narrative.
Analyst Support and the "Sell the News" Reversal
The initial post-earnings dip was driven largely by a reported GAAP net loss of about $6.6 million, reflecting a one-time charge of roughly $33 million tied to a historical UK litigation settlement and transaction costs. That headline loss overshadowed otherwise strong top-line results and triggered a brief "sell the news" reaction.
On Thursday, however, sentiment stabilized. Goldman Sachs raised its price target on GRND to $20 from $19 while maintaining a Buy rating, citing the revised guidance and the upcoming Edge launch. The reversal in tone helped shares recover from the prior session's decline.
Market Context and Trading Activity
The gain in GRND occurred amid a mixed broader tape, with technology and growth names largely outperforming. The rebound reflects a rotation back into a stock that had pulled back more than 17% over the prior three months, leaving it below its 52-week high of $18.50 but well above its 52-week low of $9.73. The recovery also follows a period of notable volatility around the earnings report, with the stock trading in a range between roughly $13.31 and $14.27 in the preceding session.
What Comes Next for GRND
Looking ahead, investors will monitor execution on several fronts for GRND. The commercial rollout of Edge will be closely watched for conversion and pricing signals, while the integration of Freddie and expansion of owned-pharmacy capacity will shape the healthcare revenue trajectory. Management has guided that advertising growth may moderate to mid-to-high-teens percentages of revenue, partly reflecting the loss of telehealth direct-ad dollars now internalized. Risks include integration costs, margin pressure as the company scales clinical infrastructure, and the broader sensitivity of high-multiple growth names to interest-rate and macro sentiment. The next earnings report and any updates on Edge adoption and Freddie integration will be key catalysts.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving investors a range of automated approaches to consider. Explore the page to see which strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
GRND's Indicator enters downward trend
The Aroon Indicator for GRND entered a downward trend on November 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 106 similar instances where the Aroon Indicator formed such a pattern. In 75 of the 106 cases the stock moved lower. This puts the odds of a downward move at 71%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GRND as a result. In 61 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GRND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GRND's RSI Indicator exited the oversold zone, 11 of 12 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for GRND just turned positive on November 04, 2026. Looking at past instances where GRND's MACD turned positive, the stock continued to rise in 37 of 53 cases over the following month. The odds of a continued upward trend are 70%.
Following a +9.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where GRND advanced for three days, in 178 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: GRND's P/B Ratio (-200.505) is slightly lower than the industry average of (-1.906). P/E Ratio (28.809) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (5.663) is also within normal values, averaging (70.383).
The Tickeron SMR rating for this company is 13 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 37 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. GRND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GRND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement